As a Medical Advisor for HistoSonics, Jeff Geschwind, MD is at the forefront of a revolution. He helps develop a non-invasive, image-guided therapy for liver cancer, offering new hope to patients by destroying tumors without a single incision, minimizing recovery time and risk. https://medicine.yale.edu/news/medicineatyale/article/two-clinical-leaders-join-medical-school-as-administrators/